Canary Staked INJ ETF aims to bring regulated Injective staking to Nasdaq

Canary Capital's amended S-1 lays out a 1.10% fee, a 90% staking target and a $15 million seed commitment from the Injective Foundation Canary Capital wants to give US investors a way to own Injective ’s INJ token and collect staking rewards without touching a crypto wallet. The vehicle is the proposed Canary Staked INJ ETF, which would trade on Nasdaq under the ticker INJC , pending approval from the Securities and Exchange Commission. If it clears that hurdle, it would become the first staked INJ ETF in the US. Canary first filed an S-1 registration statement with the SEC in July 2025. The most recent amendment landed on October 23, 2026, and it fills in many of the operational details. The core plan is simple to describe.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to Crypto Briefing.